MS vs ORCL: Which Is the Better Buy?

Side-by-side comparison of Morgan Stanley and Oracle Corporation โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-22.
Morgan Stanley ยท Financial Services
$189.30
-30.5% upside to fair value
Grade C High Quality
VS
Oracle Corporation ยท Technology
$175.08
+137.3% upside to fair value
Grade C High Quality
QuantHub Verdict
ORCL has more upside to fair value (+137.3%). MS trades at a lower forward P/E (16.4x). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric MS ORCL
Current Price $189.30 $175.08
Fair Value Estimate $131.49 $415.43
Upside to Fair Value -30.5% +137.3%
Market Cap $300.6B $503.5B
Forward P/E 16.4x 30.8x
EV / EBITDA 24.4x 21.4x
Price / Sales 2.5x 7.9x
Price / FCF -16.8x -20.4x
Revenue Growth YoY +18.8% +21.7%
Gross Margin 58.0% 66.4%
Operating Margin 19.5% 30.8%
Return on Equity 16.7% 57.4%
Dividend Yield 0% 0%
FCF Yield โ€” โ€”
Analyst Consensus Hold Strong Buy
Investment Thesis
MS โ€” Morgan Stanley
Morgan Stanley is a leading global financial services firm operating in Institutional Securities, Wealth Management, and Investment Management. The company benefits from a durable competitive moat supported by its systemically important status, diversified revenue streams, and strong management with a 36-year veteran CEO. Despite solid fundamentals including 14.2% revenue growth in 2025 and 16.7%โ€ฆ
ORCL โ€” Oracle Corporation
Oracle Corporation is a leading enterprise software and cloud infrastructure provider with a strong legacy in database technology and a growing cloud business. The company benefits from a durable competitive moat supported by high insider ownership, experienced leadership, and a history of strategic acquisitions. Oracle's recent financials show robust revenue growth of 21.7% and earnings growth oโ€ฆ
Accumulation Zones
Metric MS ORCL
Zone Low $98.62 $311.57
Zone High $111.77 $353.12
In Buy Zone? No Yes
โ† MS Research    ORCL Research โ†’    All Research